Guo Q - Search Results

1

The high-risk model associated with SYTL4 predicts poor prognosis and correlates with immune infiltration in AML.

Shi K, Li D, Peng BH, Guo Q. Shi K, et al. Among authors: guo q. Biochem Biophys Rep. 2024 Nov 29;41:101859. doi: 10.1016/j.bbrep.2024.101859. eCollection 2025 Mar. Biochem Biophys Rep. 2024. PMID: 39686961 Free PMC article.

2

Upregulated expression of MTFR2 as a novel biomarker predicts poor prognosis in hepatocellular carcinoma by bioinformatics analysis.

Li D, Ji Y, Guo J, Guo Q. Li D, et al. Among authors: guo q, guo j. Future Oncol. 2021 Aug;17(24):3187-3201. doi: 10.2217/fon-2020-1160. Epub 2021 Jun 22. Future Oncol. 2021. PMID: 34156259 Free article.

3

The Regulatory Network and Potential Role of LINC00973-miRNA-mRNA ceRNA in the Progression of Non-Small-Cell Lung Cancer.

Guo Q, Li D, Luo X, Yuan Y, Li T, Liu H, Wang X. Guo Q, et al. Front Immunol. 2021 Jul 29;12:684807. doi: 10.3389/fimmu.2021.684807. eCollection 2021. Front Immunol. 2021. PMID: 34394080 Free PMC article.

4

The value of erlotinib related target molecules in kidney renal cell carcinoma via bioinformatics analysis.

Zhang Y, Tang M, Guo Q, Xu H, Yang Z, Li D. Zhang Y, et al. Among authors: guo q. Gene. 2022 Mar 30;816:146173. doi: 10.1016/j.gene.2021.146173. Epub 2022 Jan 11. Gene. 2022. PMID: 35026294

5

The roles of risk model based on the 3-XRCC genes in lung adenocarcinoma progression.

Zhang QX, Yang Y, Yang H, Guo Q, Guo JL, Liu HS, Zhang J, Li D. Zhang QX, et al. Among authors: guo q, guo jl. Transl Cancer Res. 2021 Oct;10(10):4413-4431. doi: 10.21037/tcr-21-1431. Transl Cancer Res. 2021. PMID: 35116299 Free PMC article.

6

LncRNA NEAT1-miR-101-3p/miR-335-5p/miR-374a-3p/miR-628-5p-TRIM6 axis identified as the prognostic biomarker for lung adenocarcinoma via bioinformatics and meta-analysis.

Ding DX, Li Q, Shi K, Li H, Guo Q, Zhang YQ. Ding DX, et al. Among authors: guo q. Transl Cancer Res. 2021 Nov;10(11):4870-4883. doi: 10.21037/tcr-21-2181. Transl Cancer Res. 2021. PMID: 35116339 Free PMC article.

7

Clinical Roles of Risk Model Based on Differentially Expressed Genes in Mesenchymal Stem Cells in Prognosis and Immunity of Non-small Cell Lung Cancer.

Guo Q, Xiao XY, Wu CY, Li D, Chen JL, Ding XC, Cheng C, Chen CR, Tong S, Wang SH. Guo Q, et al. Front Genet. 2022 Feb 24;13:823075. doi: 10.3389/fgene.2022.823075. eCollection 2022. Front Genet. 2022. PMID: 35281822 Free PMC article.

8

A New Risk Model Based on 7 Quercetin-Related Target Genes for Predicting the Prognosis of Patients With Lung Adenocarcinoma.

Zhang YQ, Li K, Guo Q, Li D. Zhang YQ, et al. Among authors: guo q. Front Genet. 2022 May 13;13:890079. doi: 10.3389/fgene.2022.890079. eCollection 2022. Front Genet. 2022. PMID: 35646063 Free PMC article.

9

Interfering with ITGB1-DT expression delays cancer progression and promotes cell sensitivity of NSCLC to cisplatin by inhibiting the MAPK/ERK pathway.

Li D, Liu X, Jiang N, Ke D, Guo Q, Zhai K, Han H, Xiao X, Fan T. Li D, et al. Among authors: guo q. Am J Cancer Res. 2022 Jul 15;12(7):2966-2988. eCollection 2022. Am J Cancer Res. 2022. PMID: 35968342 Free PMC article.

10

The Roles and Mechanisms of TRAT1 in the Progression of Non-Small Cell Lung Cancer.

Guo Q, Wang SH, Ji YM, Tong S, Li D, Ding XC, Wu CY. Guo Q, et al. Curr Med Sci. 2022 Dec;42(6):1186-1200. doi: 10.1007/s11596-022-2625-1. Epub 2022 Oct 3. Curr Med Sci. 2022. PMID: 36184729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,666 results

Search Page

Filters